Pharma Foods International Co., Ltd. (hereinafter: PFI) announces that Takeda Pharmaceutical Co., Ltd. has exercised its contractual option to acquire the sequence information of a chicken-derived antibody, generated using PFI's proprietary antibody discovery platform, ALAgeneⓇ technology.
(PDF, 237KB)